Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with primary Sjögren's syndrome based on a specific set of internationally recognised diagnostic guidelines (called the American-European Consensus Criteria)
- People who have been informed about the study and have signed the consent form agreeing to take part
Who may not be able to join:
- People whose Sjögren's syndrome is caused by or linked to another condition (called secondary Sjögren's syndrome)
- People who also have another systemic autoimmune disease, such as rheumatoid arthritis, a condition called ANCA-associated vasculitis, or mixed connective tissue disease
- People who are unable to sign, or who do not wish to sign, the consent form
- People who are unable to attend, or who do not wish to attend, the follow-up appointments required by the study
- People who have been treated with certain medications — including abatacept, sifalimumab, rontalizumab, anifrolumab, belimumab, TNF blockers, or interferon — within the 6 months before joining the trial
- People who currently have signs or symptoms of an active infection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pascal CATHEBRAS, MD PhD, Centre Hospitalier Universitaire de Saint Etienne
Phone: (0)477828342
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of anti-Ro/SSA IgE positive patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.